Publications

5674 Results

Intervention non-adherence in a pragmatic randomized trial of a standardized order entry for colony stimulating factor prescribing

Authors
D Hershman;A Bansal;W Barlow;K Arnold;A Bell-Brown;K Watabayashi;K Kreizeneck;S Sullivan;G Lyman;S Ramsey
Journal / Conference
ASCO Quality Care Symposium (September 30 - October 1, 2022, Chicago, IL), oral presentation
Year
2022
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

How many stratification factors are reasonable and can there be too many? Evaluation of analysis strategies in the context of a randomized Phase 2 trial in acute myeloid leukemia within the myeloMATCH platform

Authors
A Moseley;B Freidlin;R Shallis;A Zeidan;D Sallman;R Little;H Erba;M LeBlanc;M Othus
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), poster
Year
2022
Research Committee(s)
Leukemia
Study Number(s)
MYELOMATCH

Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma ECOG-ACRIN E1411

Authors
M Smith;O Jegede;P Martin;B Till;S Parekh;D Yang;L Kostakoglu Shields;C Casulo;N Bartlett;P Caimi;T Al Baghdadi;K Maddocks;M Romer;D Inwards;R Lerner;L Wagner;R Little;JW Friedberg;J Leonard;B Kahl
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), oral presentation
Year
2022
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1411

RANDOMIZED PHASE II TRIAL OF NEOADJUVANT GEMCITABINE, AVELUMAB AND CARBOPLATIN VS. NO NEOADJUVANT THERAPY PRECEDING SURGERY FOR CISPLATIN-INELIGIBLE MUSCLE-INVASIVE UROTHELIAL CARCINOMA (MIUC): SWOG GAP TRIAL (S2011)

Authors
G Sonpavde;M Plets;M Liss;J Meeks;D Petrylak;S Cole;R McKay;S Gupta;T Pereira;R Bangs;C Tangen;IM Thompson;SP Lerner
Journal / Conference
Society of Urologic Oncology (Nov 30, 2022 - Dec 02, 2022, San Diego, CA), poster
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S2011

A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of ECOG-ACRIN EA9131

Authors
A Jillella;S Lee;J Altman;S Luger;M Tallman;J Foran;L Law;L Bryan;A Zahr;K Begna;A Perl;J Vadakara;F Sanchez;R Bergan;M Fisch;R Carlos;L Wagner;M Litzow;V Kota
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), oral
Year
2022
Research Committee(s)
Cancer Survivorship

A Robust Long Non-Coding RNA Expression Classifier for Risk Stratification in Pediatric AML

Authors
J Farrar;J Smith;M Othus;B Huang;Y Wang;R Ries;T Hylkema;E Pogosova-Agadjanyan;A Leonti;T Shaw;T Triche;A Gamis;R Aplenc;E Kolb;X Ma;D Stirewalt;T Alonzo;S Meshinchi
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), poster
Year
2022
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-9031, SWOG-9333

Renal Toxicity with Carfilzomib in Multiple Myeloma: Secondary Analysis of SWOGS1304 Comparing Low-Dose Versus High-Dose Carfilzomib

Authors
R Chakraborty;R Sexton;Lentzsch;M Abidi;P Voorhees;A Cohen;E Rohren;S Heitner;K Kelly;N Mackler;D Baer;A Hoering;B Durie;S Ailawadhi;R Orlowski
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), poster
Year
2022
Research Committee(s)
Myeloma
Study Number(s)
S1304

EXPLORATORY ANALYSES FROM SWOG S1801

Authors
SP Patel;M Othus;V Prieto;M Lowe;E Buchbinder;J Kirkwood;L Korde;J Moon;V Sondak;E Sharon;A Ribas
Journal / Conference
Melanoma Bridge Meeting (Dec 1-3.2-22, Napoli, Italy), oral
Year
2022
Research Committee(s)
Melanoma
Study Number(s)
S1801

Umbrella Trial in Myeloid Malignancies: the myeloMATCH National Clinical Trials Network Precision Medicine Initiative

Authors
R Little;M Othur;S Assouline;S Ansher;E Atallah;C Lindsley;B Freidlin;S Gore;L Harris;C Hourigan;S Ivey;S Jiwani;E Langan;S Lunger;L Michaelis;O Odenike;D Patton;M Pereles;J Radich;B Ramineni;J Salk;P Stiff;W Stock;R Stone;G Uy;P Williams;B Wood;K Worthington;L Yee;A Zeidan;J Zhang;M Litzow;H Erba
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), poster
Year
2022
Research Committee(s)
Leukemia
Study Number(s)
MYELOMATCH

Antiviral Therapy Use and Related Outcomes in Patients with Cancer and Viral Infections: Results from SWOG S1204

Authors
J Hwang;K Arnold;J Unger;R Chugh;M Tincopa;R Loomba;D Hershman;S Ramsey
Journal / Conference
Supportive Care in Cancer Dec 31;31(1):93
Year
2022
Research Committee(s)
Cancer Care Delivery
PMID
PMID36585488
PMC
PMC9803880
Study Number(s)
S1204